李氏医学探索

荆志成丨Some Thoughts on New Drug Development for Pulmonary Arterial Hypertension, A Rare Disease

2019-10-16

▲ 视频缓冲需时，请耐心等待！

下一篇：Hiromi Matsubara丨Lowering mPAP as treatment goal in PAH (China)

上一篇：顾虹丨Treprostinil in Pediatric PAH- Experience Sharing

写评论...